Fortress Biotech, Inc. Operating Leases, Future Minimum Payments, Due in Three Years
Fortress Biotech, Inc. (FBIO) had Operating Leases, Future Minimum Payments, Due in Three Years of $3.08 million as of 2018-12-31, per its 10-Q filed 2019-11-12.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears · last filed 2019-11-12
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $3.08M.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $3.20M.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $2.71M.
- 2016-09-30: Operating Leases, Future Minimum Payments, Due in Three Years $1.46M.
| Period end | Operating Leases, Future Minimum Payments, Due in Three Years |
|---|---|
| 2018-12-31 | $3.08M 10-Q · filed 2019-11-12 |
| 2017-12-31 | $3.20M 10-K · filed 2018-03-16 |
| 2016-12-31 | $2.71M 10-K · filed 2017-03-16 |
| 2016-09-30 | $1.46M 10-Q · filed 2016-11-09 |
| 2015-12-31 | $2.78M 10-K · filed 2016-03-15 |
| 2014-12-31 | $2.56M 10-K · filed 2015-03-16 |
| 2013-12-31 | $291.00K 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |